Russia Completed Clinical Trials Of Second Potential COVID-19 Vaccine
Category:
Coronavirus
MOSCOW: Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.
The institute completed early-stage human trials, known as Phase II, earlier this month.
SOURCE: THEPENINSULAQATAR
30 Sep, 2020
0
869
Posted Comments
Related News